Calculation of coronary risk in Type II diabetes

Clinical Science

Volumn 101, Issue 6, 2001, Pages 681-682

  Durrington, P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CORONARY RISK; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 0035215121     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010246     Document Type: Note

References (20)

1. The UKPDS risk engine: A model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
2. Cardiovascular disease risk profiles
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
4. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
5. Joint British recommendations on prevention of coronary heart disease in clinical practice
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
7. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose: Subgroup analyses in the Scandinavian Simvastatin Survival Study
8. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. Subgroup analyses in the Cholesterol and Recurrent Events (CARE) trial
9. Prevention of cardiovascular events and death with pravastatin in patients with coronary disease and a broad range of initial cholesterol levels
10. Diabetic Dyslipidaemia
11. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
12. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
13. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
14. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
15. Cardiovascular risk factors in confirmed prediabetic individuals: Does the clock for coronary disease start ticking before the onset of clinical diabetes
16. Pravastatin and the development of diabetes mellitus. Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
17. Joint British recommendations on prevention of coronary heart disease in clinical practice: Summary
18. Management of dyslipidaemia in adults with diabetes
19. Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes: MRC/BHF Heart Protection Study and other major trials